SPACInsider Logo
The Latest SPAC News and Rumors: September 17, 2021
by Marlena Haddad on 2021-09-17 at 12:02pm

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Hong Kong considers allowing SPAC listings, Redbox Entertainment acquires Vendetta distribution rights, and EQRx announces presentation of phase 3 data

Hong Kong Proposes SPAC Listings, But Only for Professional Investors

Hong Kong Exchanges & Clearing has outlined plans to allow the listing of blank-check corporations whose global popularity has soared over the past year, just two weeks after regional rival Singapore greenlit the float of such entities.

HKEX, however, proposes to take a more cautious approach than Singapore or the U.S.

Under the proposal offer for public comment on Friday, only institutional investors or individuals with a portfolio worth at least 8 million Hong Kong dollars ($1.03 million) would be allowed to invest in Hong Kong SPACs.


Redbox Entertainment Acquires U.S. Distribution Rights to Action Thriller Movie Vendetta

Redbox Entertainment, the original content division of Redbox, today announced it has acquired U.S. distribution rights to the action-thriller movie Vendetta.  The film will premiere in 2022 and is expected to have a limited theatrical run and be available day-and-date On Demand.

Redbox recently announced a definitive agreement to combine with Seaport Global Acquisition Corp. (NASDAQ:SGAM).


EQRx Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit 

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced a late-breaking mini oral presentation of data from its partner CStone Pharmaceuticals’ Phase 3 GEMSTONE-301 study at the European Society for Medical Oncology (ESMO) Congress 2021.

GEMSTONE-301 is a placebo-controlled Phase 3 trial evaluating the efficacy and safety of the anti-PD-L1 antibody sugemalimab as consolidation therapy in patients with locally advanced/unresectable Stage III non-small cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy.

In August 2021, EQRx announced a proposed combination with CM Life Sciences III (NASDAQ: CMLTU) to accelerate growth.



Recent Posts
by Marlena Haddad on 2023-06-01 at 5:33pm

Latest SPAC Liquidations: JAWS Hurricane JAWS Hurricane Acquisition Corporation (HCNE) to Liquidate on June 16 JAWS Hurricane Acquisition Corporation (Nasdaq: HCNE) today announced that its board of directors has determined not to proceed with a proposal to extend its corporate existence. As such, the Board has determined to cancel the special meeting of its stockholders,...

by Marlena Haddad on 2023-06-01 at 5:26pm

Jupiter Wellness Acquisition Corp. (NASDAQ:JWAC) announced this afternoon that it has completed its combination with Chinese carmaker Chijet. The deal was already approved by shareholders at a special meeting held on May 2, but at that time, the SPAC did not provide a timeline for the closing of the transaction. Although redemption numbers have still not...

by Nicholas Alan Clayton on 2023-06-01 at 2:41pm

The advent of summer is bringing nine lock-up expirations for de-SPAC’d companies and 10 on the sponsor side. The first change is to come for the sponsor of European Biotech Acquisition Corp., which closed its combination with Swiss pharma firm Oculis SA (NASDAQ:OCS) just three months ago. The sponsor is getting flexibility at a good...

by Marlena Haddad on 2023-06-01 at 11:34am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Lucid to raise $3B in a common stock offering from Saudi owners, Betsy Cohen says SPACs will make a comeback, and SatixFy makes another leadership change  Lucid Raising $3 Billion With More Money From...

by Kristi Marvin on 2023-06-01 at 9:36am

An article on Bloomberg yesterday announced what many in SPAC Land have been wondering after UBS acquired Credit Suisse – where was Niron Stabinsky, the Head of SPACs at Credit Suisse, going to land? The answer is Banco Santander SA, in what appears to be a massive lift of most (or nearly all) of Credit...

Privacy Policy|Terms Of Use
Copyright © 2023 SPACInsider, Inc. All Rights Reserved